Total Payments
$4,069
2022 Payments
$86.94
Companies
16
Transactions
147
Medicare Patients
2,460
Medicare Billing
$78,569
Payment Breakdown by Category
Food & Beverage$4,062 (99.8%)
Education$6.97 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,062 | 146 | 99.8% |
| Education | $6.97 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,262 | 42 | $0 (2022) |
| Amgen Inc. | $1,005 | 19 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $303.80 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $290.59 | 10 | $0 (2022) |
| PFIZER INC. | $280.85 | 24 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $233.56 | 12 | $0 (2021) |
| Boston Scientific Corporation | $206.19 | 9 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $99.56 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $64.50 | 3 | $0 (2017) |
| Allergan Inc. | $60.26 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $86.94 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28.74) |
| 2021 | $444.85 | 20 | Janssen Pharmaceuticals, Inc ($221.25) |
| 2020 | $627.09 | 30 | Janssen Pharmaceuticals, Inc ($386.01) |
| 2019 | $622.77 | 29 | Janssen Pharmaceuticals, Inc ($138.02) |
| 2018 | $1,042 | 32 | Amgen Inc. ($543.91) |
| 2017 | $1,245 | 31 | Janssen Pharmaceuticals, Inc ($329.05) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: DIABETES | ||||||
| 02/28/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiology | ||||||
| 02/16/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/02/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: DIABETES | ||||||
| 09/08/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/01/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Cardiology | ||||||
| 08/06/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $119.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiology | ||||||
| 03/19/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/11/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.90 | General |
| Category: Cardiovascular | ||||||
| 03/04/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: DIABETES | ||||||
| 02/25/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Cardiovascular | ||||||
| 02/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/18/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/04/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JENTADUETO (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: DIABETES | ||||||
| 01/13/2021 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/07/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 283 | 363 | $67,586 | $3,743 |
| 2022 | 7 | 519 | 605 | $80,988 | $11,253 |
| 2021 | 10 | 826 | 1,023 | $126,882 | $32,482 |
| 2020 | 10 | 832 | 1,055 | $118,116 | $31,091 |
Total Patients
2,460
Total Services
3,046
Medicare Billing
$78,569
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 251 | 331 | $63,746 | $2,044 | 3.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 32 | 32 | $3,840 | $1,699 | 44.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 352 | 434 | $63,038 | $2,747 | 4.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 49 | 49 | $5,880 | $2,735 | 46.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $3,325 | $2,586 | 77.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 27 | $3,375 | $1,863 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 25 | $2,125 | $832.23 | 39.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 14 | $840.00 | $248.25 | 29.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 35 | 37 | $2,405 | $240.57 | 10.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 55 | 55 | $9,625 | $7,587 | 78.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 53 | $6,625 | $4,258 | 64.3% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 28 | 30 | $5,700 | $4,106 | 72.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 483 | 580 | $79,887 | $3,847 | 4.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 67 | $5,695 | $3,773 | 66.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 53 | 55 | $6,600 | $3,200 | 48.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 28 | 49 | $3,920 | $2,616 | 66.7% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 15 | 47 | $3,290 | $1,560 | 47.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 23 | $1,380 | $896.79 | 65.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 58 | 64 | $4,160 | $637.60 | 15.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 56 | 56 | $9,800 | $6,786 | 69.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 60 | $7,500 | $4,237 | 56.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 496 | 606 | $70,626 | $4,081 | 5.8% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 24 | 29 | $5,510 | $3,893 | 70.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 67 | $5,695 | $3,198 | 56.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 48 | 48 | $5,760 | $2,949 | 51.2% |
About Dr. Jack Klie, MD
Dr. Jack Klie, MD is a Cardiovascular Disease healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992876080.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Klie, MD has received a total of $4,069 in payments from pharmaceutical and medical device companies, with $86.94 received in 2022. These payments were reported across 147 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,062).
As a Medicare-enrolled provider, Klie has provided services to 2,460 Medicare beneficiaries, totaling 3,046 services with total Medicare billing of $78,569. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Providence, RI
- Active Since 11/13/2006
- Last Updated 03/13/2009
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1992876080
Products in Payments
- XARELTO (Drug) $1,255
- Repatha (Biological) $891.49
- ELIQUIS (Drug) $312.34
- ENTRESTO (Drug) $288.81
- JARDIANCE (Drug) $219.35
- WATCHMAN (Device) $206.19
- CHANTIX (Drug) $186.69
- Corlanor (Drug) $113.70
- PRALUENT (Drug) $99.56
- Lexiscan (Drug) $64.50
- BYSTOLIC (Drug) $60.26
- BRILINTA (Drug) $59.22
- Vascepa (Drug) $53.67
- Livalo (Drug) $53.45
- PRADAXA (Drug) $50.63
- INJECTAFER (Drug) $45.89
- PRALUENT (Biological) $30.29
- Ozempic (Drug) $20.76
- JENTADUETO (Drug) $20.61
- VIAGRA (Drug) $15.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Providence
Mrs. Jinnette Abbott, Md, MD
Cardiovascular Disease — Payments: $153,138
Cardiovascular Disease $153,138
Ara Sadaniantz, Md, MD
Cardiovascular Disease — Payments: $84,120
Cardiovascular Disease $84,120
John Cava, Md, MD
Cardiovascular Disease — Payments: $57,223
Cardiovascular Disease $57,223
Dr. Carlos Cuello
Cardiovascular Disease — Payments: $19,646
Cardiovascular Disease $19,646
Dr. Franklin Schneider, Md, MD
Cardiovascular Disease — Payments: $15,467
Cardiovascular Disease $15,467
Jeremy Lum, Md, MD
Cardiovascular Disease — Payments: $12,810
Cardiovascular Disease $12,810